AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/article-1G1-112140297/roche-and-trimeris-halt.html" title="Facts and information about Roche and Trimeris halt trials of HIV drug.(Brief Article)">Roche and Trimeris halt trials of HIV drug.(Brief Article)</a>

Close Set up an RSS feed that alerts you when new articles from Pharma Marketletter are available.

Frequently asked questions about RSS feeds

Roche and Trimeris halt trials of HIV drug.(Brief Article)

Pharma Marketletter

| January 05, 2004 | COPYRIGHT 2009 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Swiss drug major Roche and US partner Trimeris have halted clinical trials of an investigational HIV drug called T-1249. The companies said they had stopped the studies because of problems with its formulation. Shares in Trimeris were down 16% to $17.00 in morning trading on January 6, following the late announcement on the previous day. Roche certificates were …

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


BioInvent initiates trial of anti-HIV drug.(Brief Article): Newspaper article from: Pharma Marketletter July 4, 2005 700+ words
...Lund, Sweden-headquartered drugmaker BioInvent has initiated Phase I/IIa clinical studies of its candidate anti-HIV drug, BI-201. The agent is a human antibody selected from the firm's n-CoDeR antibody library for its ability to bind...


Tibotec-Virco initiating U.S. trials of HIV drug.(Brief Article): Newspaper article from: BioWorld International Etheridge, James January 2, 2002 700+ words
PARIS -- Tibotec-Virco NV plans to embark on Phase I clinical trials of its anti-HIV drug candidate TMC125 in the U.S., following the completion of the FDA's review of its investigational new drug application...


Medivir AB and GlaxoSmithKline sign licensing agreement on HIV drug.(Brief...: Newspaper article from: Nordic Business Report May 21, 2003 700+ words
NORDIC BUSINESS REPORT-21 May 2003-Medivir AB and GlaxoSmithKline sign licensing agreement on HIV drug(C)1994-2003 M2 COMMUNICATIONS LTD http://www.m2.com The Swedish pharmaceuticals developer Medivir AB said on Tuesday...


Triangle files first NDA, seeks Coviracil approval.(new drug application for...: Newspaper article from: BioWorld Week September 9, 2002 700+ words
...6 percent. By comparison, the stock closed at $2.88, up 53 cents, after release of the positive interim data for the HIV drug called Coviracil. Coviracil (emtricitabine) is a nucleoside reverse transcriptase inhibitor licensed from Emory University...


Deaths prompt strengthened Viramune label.(Boehringer Ingelheim/Roxane...: Magazine article from: Medical Marketing & Media Dickinson, James G. January 1, 2001 700+ words
* Boehringer Ingelheim/Roxane Laboratories has strengthened label warnings for its HIV drug Viramune (nevirapine) in response to continued reports of severe, life-threatening and in some cases fatal hepatotoxicity...


Assay IDs High HIV Drug Susceptibility.(Brief Article): Newspaper article from: Drug Discovery & Technology News July 1, 2001 700+ words
...significantly improved by using highly sensitive PhenoSense HIV drug resistance assay to determine enhanced susceptibility or...president of clinical research. "After years spent studying HIV drug resistance, we are beginning to understand the flip-side...


Tripep reports disappointing results from HIV drug study.(Brief Article): Newspaper article from: Nordic Business Report March 29, 2002 700+ words
...29 March 2002-Tripep reports disappointing results from HIV drug study (C)1994-2002 M2 COMMUNICATIONS LTD http://www...completed a final analysis of the clinical, phase II study of its HIV drug GBP, CTN 002. According to Tripep, the results show that...


Global initiative launched to combat HIV drug resistance.(Brief Article): Newspaper article from: AIDS Weekly August 12, 2002 700+ words
...initiative in HIV management was launched at the XI International HIV Drug Resistance Workshop. The International HIV Resistance Response...develop a predictive tool that could be the key to managing HIV drug resistance in the future." The RDI is made up of an expanding...


RDI: Global initiative launched to combat HIV drug resistance.(Brief Article): Newspaper article from: AIDS Weekly August 12, 2002 700+ words
...initiative in HIV management was launched at the XI International HIV Drug Resistance Workshop. The International HIV Resistance Response...develop a predictive tool that could be the key to managing HIV drug resistance in the future." The RDI is made up of an expanding...


Virco Launches Online Physician Access to Its HIV Drug Service.(Brief Article): Newspaper article from: Virus Weekly October 3, 2000 700+ words
...Kingdom, announced the availability of online access to their HIV drug resistance tests via a new service named VircoTrack, reportedly...also provided. Access to the results of previous completed HIV drug resistance tests will help the physician follow the evolution...

For more facts and information, see all results

Source: HighBeam Research, Roche and Trimeris halt trials of HIV drug.(Brief Article)

The AccessMyLibrary advertising network includes: